The Potential of Technology to Improve Chronic Disease Management and Quality of Care

Sponsor
Robert Wood Johnson Foundation (Other)
Overall Status
Completed
CT.gov ID
NCT00221455
Collaborator
(none)
1,000
1
36
27.8

Study Details

Study Description

Brief Summary

We seek to determine if patient data entry, data entered based alerts, and data review in a secure patient portal may provide a sustainable approach to improve diabetic outcomes in a cost effective manner. We plan to study the extent to which the portal can improve diabetic outcomes and quality of care. We recognize, however, that some patients will be more predisposed to adopting technology and some will be more predisposed to improving their compliance than others. Hence, we will also develop and test interventions that may improve adoption and compliance. The goals of the proposed study are: 1) to assess whether a web portal will improve care outcomes in diabetic patients; 2a) to describe the characteristics of patients whose health behavior improves over the study period; 2b) to describe the characteristics of patients who adopt the web portal-based disease management technology; 3) to develop and test targeted interventions to increase the adoption of the web portal and improve patient health behavior; and 4) to monitor the ongoing costs associated with the web portal and patient healthcare resource utilization, and to monitor the incremental costs of the interventions designed to improve utilization of the technology and patient compliance with their diabetic regimens.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Patient diabetic self-management using the diabetic patient portal tools
  • Behavioral: A variety of educational interventions for non-adopters of the technology, and for non-compliant patients.
Phase 1

Detailed Description

To date, limited research has been conducted to determine if health information technology (HIT) is effective in improving the outcomes for patients with chronic diseases. Research is required to determine if interventions facilitated by an institutional EMR platform can be implemented such that they support patients with chronic diseases to achieve improved outcomes in a cost effective fashion.

At the Cleveland Clinic Foundation (CCF) an ambulatory EMR has been implemented to foster patient safety and institutional best practice guidelines, to facilitate research, and to achieve efficiencies in practice management. Our EMR is the foundation of the CCF patient portal. One of the functions of the portal is to allow patients to enter specific data elements that become part of their permanent medical record. Diabetics can enter and review their home glucometer readings, and view alert messages based on their entries. The entries are transferred to the patient's primary care physician's EMR In-Basket for review.

We recognize that some patients will be more predisposed to technology adoption and some will be more health behavior compliant than others. Therefore, in addition to studying our portal's efficacy in positive diabetic behavior change, we will test if interventions can assist less predisposed and less compliant patients to become more compliant and more inclined to adopt the technology.

The goals of the proposed study are:
  1. to assess whether a web portal will improve care outcomes in diabetic patients; 2a) to describe the characteristics of patients whose health behavior improves over the study period; 2b) to describe the characteristics of patients who adopt the web portal-based disease management technology; 3) to develop and test targeted interventions to increase the adoption of the web portal and improve patient health behavior; 4) to monitor the ongoing costs associated with the web portal and patient healthcare resource utilization, and to monitor the incremental costs of the interventions designed to improve utilization of the technology and patient compliance with their diabetic regimens.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1000 participants
Allocation:
Non-Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Potential of Technology to Improve Chronic Disease Management and Quality of Care
Study Start Date :
Sep 1, 2004
Actual Study Completion Date :
Sep 1, 2007

Outcome Measures

Primary Outcome Measures

  1. Clinical Outcome Measures: HbA1c, LDL,and the presence or absence of clinically significant proteinuria. []

Secondary Outcome Measures

  1. Technology Adoption will be measured by tracking the patient usage of the various portal features []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria: Diabetic patients 18 years of age or older with an established primary care physician at the Cleveland Clinic Foundation

Exclusion Criteria: An individual not meeting the inclusion criteria

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Cleveland Clinic Foundation Cleveland Ohio United States 44195

Sponsors and Collaborators

  • Robert Wood Johnson Foundation

Investigators

  • Principal Investigator: Martin Harris, MD, MBA, The Cleveland Clinic
  • Study Director: Holly D Miller, MD, MBA, The Cleveland Clinic

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00221455
Other Study ID Numbers:
  • 51760
  • 51760
First Posted:
Sep 22, 2005
Last Update Posted:
Jul 27, 2011
Last Verified:
Jul 1, 2011

Study Results

No Results Posted as of Jul 27, 2011